Dr. Anshul Varshney, MD

Dr. Varshney practices at Chino Hills Eye & Laser Center in Chino, California.

Dr. Varshney's NPI, 1619155991, was assigned on February 8, 2008. Dr. Varshney graduated from UC Irvine School of Medicine in 2001. Dr. Varshney holds California license A84378.

Dr. Varshney's primary practice is Chino Hills Eye & Laser Center, at 13768 Roswell Ave, Chino, CA 91710-1401. The practice phone is (909) 627-3210.

Dr. Varshney's primary practice is Chino Hills Eye & Laser Center in Chino, California. Dr. Varshney is also affiliated with Pomona Valley Hospital Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Varshney practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Varshney's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Varshney is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Varshney's licenses on file in 2 states: California and Louisiana.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Varshney treats.

CMS data shows 1,768 Medicare services from Dr. Varshney across 17 procedure codes in 2024, for 449 Medicare patients. Medicare paid $164,926 for them.

CMS counts 449 Medicare patients who saw Dr. Varshney in 2024. The largest group is 65 to 74, with 244 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 37% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Varshney's median patient age at 66, with 58% women.

In 2024, Dr. Varshney wrote 2,300 Medicare Part D claims for 385 patients. 63% of them were for generic drugs. CMS names the drug for 2,218 of them, across 21 drugs with 11 or more claims each, at $148,364 in total drug cost. In 2023, CMS named 1,869 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Varshney for performance year 2024, reported individually. Dr. Varshney accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 67 procedures of cataract surgery by Dr. Varshney, more than 68% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Varshney, published from 2016 to 2021. 2019 was the busiest year, with 2. The most frequent topics are Anthrax, Antigens, Bacterial and Bacillus anthracis. Dr. Varshney has published most often in Biologicals. Dr. Varshney's most frequent co-author is Manoj Kumar, MBBS, MD.

CMS Open Payments shows 45 general payments to Dr. Varshney from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Alcon Laboratories Inc paid the most, $639.

Dr. Varshney graduated from UC Irvine School of Medicine in 2001.

Dr. Varshney is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.